These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7981201)

  • 1. Reciprocated matrix metalloproteinase activation: a process performed by interstitial collagenase and progelatinase A.
    Crabbe T; O'Connell JP; Smith BJ; Docherty AJ
    Biochemistry; 1994 Dec; 33(48):14419-25. PubMed ID: 7981201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
    Will H; Atkinson SJ; Butler GS; Smith B; Murphy G
    J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.
    Knäuper V; Will H; López-Otin C; Smith B; Atkinson SJ; Stanton H; Hembry RM; Murphy G
    J Biol Chem; 1996 Jul; 271(29):17124-31. PubMed ID: 8663255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13).
    Knäuper V; Smith B; López-Otin C; Murphy G
    Eur J Biochem; 1997 Sep; 248(2):369-73. PubMed ID: 9346290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain.
    Crabbe T; Ioannou C; Docherty AJ
    Eur J Biochem; 1993 Dec; 218(2):431-8. PubMed ID: 8269931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1.
    Crabbe T; Zucker S; Cockett MI; Willenbrock F; Tickle S; O'Connell JP; Scothern JM; Murphy G; Docherty AJ
    Biochemistry; 1994 May; 33(21):6684-90. PubMed ID: 7911325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human progelatinase A by collagenase and matrilysin: activation of procollagenase by matrilysin.
    Sang QA; Bodden MK; Windsor LJ
    J Protein Chem; 1996 Apr; 15(3):243-53. PubMed ID: 8804571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
    Fridman R; Toth M; Peña D; Mobashery S
    Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic and non-proteolytic activation of human neutrophil progelatinase B.
    Sang QX; Birkedal-Hansen H; Van Wart HE
    Biochim Biophys Acta; 1995 Sep; 1251(2):99-108. PubMed ID: 7669817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
    Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
    Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent collagenase and gelatinase from human neutrophils and their activation.
    Tschesche H; Knäuper V; Krämer S; Michaelis J; Oberhoff R; Reinke H
    Matrix Suppl; 1992; 1():245-55. PubMed ID: 1480034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain.
    Fang KC; Raymond WW; Blount JL; Caughey GH
    J Biol Chem; 1997 Oct; 272(41):25628-35. PubMed ID: 9325284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase.
    Kolkenbrock H; Hecker-Kia A; Orgel D; Ulbrich N; Will H
    Biol Chem; 1997 Feb; 378(2):71-6. PubMed ID: 9088534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity.
    Pei D; Weiss SJ
    J Biol Chem; 1996 Apr; 271(15):9135-40. PubMed ID: 8621565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation.
    Zucker S; Mirza H; Conner CE; Lorenz AF; Drews MH; Bahou WF; Jesty J
    Int J Cancer; 1998 Mar; 75(5):780-6. PubMed ID: 9495249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2.
    Lichte A; Kolkenbrock H; Tschesche H
    FEBS Lett; 1996 Nov; 397(2-3):277-82. PubMed ID: 8955363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties.
    Imai K; Yokohama Y; Nakanishi I; Ohuchi E; Fujii Y; Nakai N; Okada Y
    J Biol Chem; 1995 Mar; 270(12):6691-7. PubMed ID: 7896811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.
    Kinoshita T; Sato H; Takino T; Itoh M; Akizawa T; Seiki M
    Cancer Res; 1996 Jun; 56(11):2535-8. PubMed ID: 8653693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 9-kDa N-terminal propeptide domain of MT1-MMP is required for the activation of progelatinase A.
    Cao J; Drews M; Lee HM; Conner C; Bahou WF; Zucker S
    Ann N Y Acad Sci; 1999 Jun; 878():710-2. PubMed ID: 10415815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.